Single Rising Dose Trial of Spesolimab (BI 655130) for Healthy Japanese Male Subjects

NCT03123094 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Spesolimab
DRUG: Placebo

Sponsor

Boehringer Ingelheim